Sun-related factors, Betapapillomavirus, and actinic keratoses: A prospective study

Archives of Dermatology

Volumn 143, Issue 7, 2007, Pages 862-868

  McBride, Penelope ^a,c   Neale, Rachel ^a,b   Pandeya, Nirmala ^a   Green, Adèle ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b CANCER COUNCIL QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; AUSTRALIA; COHORT ANALYSIS; DISEASE ASSOCIATION; EYEBROW; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUN EXPOSURE; VIRUS INFECTION;

ADULT; AGED; BETAPAPILLOMAVIRUS; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; QUEENSLAND; RISK FACTORS; SUNLIGHT;

EID: 34447544598     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.7.862     Document Type: Article

References (47)

1. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol. 1994;131(4):455-464.
2. Memon AA, Tomenson JA, Bothwell J, Friedmann PS. Prevalence of solar damage and actinic keratoses in a Merseyside population. Br J Dermatol. 2000;142(6):1154-1159.
3. Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a Queensland community. J Invest Dermatol. 2000;115(2):273-277.
4. Green A, Beardmore G, Hart V, et al. Skin cancer in a Queensland population. J Am Acad Dermatol. 1988;19(6):1045-1052.
5. Boxman ILA, Russell A, Mulder LHC, et al. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses. J Invest Dermatol. 2001;117(5):1108- 1112.
6. Struijk L, Hall L, van der Meijden E, et al. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(3):529-535.
7. Pfister H, Fuchs PG, Majewski S, et al. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res. 2003;295(7):273-279.
8. Forslund O, Ly H, Reid C, Higgins G. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol. 2003;149(1):64-73.
9. Favre M, Ramoz N, Orth G. Human papillomaviruses: general features. Clin Dermatol. 1997;15(2):181-198.
10. Ishiji T, Ibe M, Kawase M, Niimura M. Patients with epidermodysplasia verruciformis show no response to contact immunotherapy. Dermatology. 2001;202(1):76-77.
11. de Villiers E-M, Fauquet C, Broker H, et al. Classification of papillomavirus. Virology. 2004;324(1):17-27.
12. Weissenborn SJ, Nindl I, Purdie KJ, et al. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol. 2005;125(1):93-97.
13. Forslund O, Lindelöf B, Hradil E, et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "stripped" skin biopsies from the same tumors. J Invest Dermatol. 2004;123(2):388-394.
14. Astori G, Lavergne D, Benton C, et al. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol. 1998;110(5):752-755.
15. Boxman ILA, Berkhout RJM, Mulder LHC, et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol. 1997;108(5):712-715.
16. Syverton JT. The pathogenesis of the rabbit papillomato-carcinoma sequence. Ann N Y Acad Sci. 1952;54(6):1126-1140.
17. Orth G. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Ciba Found Symp. 1986;120:157-174.
18. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in renal transplant patients. Lancet. 1995;346(8972):403-406.
19. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348(17):1681-1691.
20. Meyer T, Arndt R, Christophers E, Nindl I, Stockfleth E. Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev. 2001;25(6):533-547.
21. Harwood CA, Surentheran T, Sasieni P, et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol. 2004;150(5):949-957.
22. Termorshuizen F, Feltkamp MCW, Struijk L, et al. Sunlight exposure and (sero) prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol. 2004;122(6):1456-1462.
23. Feltkamp MCW, Broer R, di Summa FM, et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with non-melanoma skin cancer. Cancer Res. 2003;63(10):2695-2700.
24. Valery PC, Neale R, Williams G, et al. The effect of skin examination surveys on the incidence of BCC in a Queensland population: a ten-year longitudinal study. J Investig Dermatol Symp Proc. 2004;9(2):148-151.
25. Green A, Battistutta D, Hart V, et al. The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants. Control Clin Trials. 1994;15(6):512-522.
26. Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet. 1999;354(9180):723-729.
27. Berkhout RJM, de Jong-Tieben LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol. 1995;33(3):690-695.
28. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer. 1990;46(3):356-361.
29. Neale RE, Purdie JL, Hirst LW, Green AC. Sun exposure as a risk factor for nuclear cataract in an Australian community. Epidemiology. 2003;14(6):707-712.
30. van der Pols JC, Xu C, Boyle GM, et al. Sunscreen use and time spent outdoors are associated with expression of the p53 tumor suppressor protein in sun-exposed skin: a community-based study. Am J Epidemiol. 2006;163(11):982-988.
31. Neale R, Russell A, Muller HK, Green A. Sun exposure, sunscreen and their effects on epidermal Langerhans cells. Photochem Photobiol. 1997;66(2):260-264.
32. Frost CA, Green A, Williams GM. The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol. 1998;139(6):1033-1039.
33. Biliris KA, Koumantakis E, Dokianakis DN, Sourvinos G, Spandidos DA. Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts. Cancer Lett. 2000;161(1):83-88.
34. Boxman ILA, Russell A, Mulder LHC, et al. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. Int J Cancer. 2000;86(1):118-121.
35. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis. 2002;15(2):101-114.
36. Masini C, Fuchs PG, Gabrielli F, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol. 2003;139(7):890-894.
37. Struijk L, Bouwes Bavinck JN, Wanningen P, et al. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol. 2003;121(6):1531-1535.
38. Bataille V, Sasieni P, Grulich A, et al. Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi. Int J Cancer. 1998;78(1):8-12.
39. Helfand M, Gorman AK, Mahon S, Chan BKS, Swanson N. Actinic Keratoses: Final Report. Portland: Oregon Health and Science University Evidence-based Practice Centre; 2001:1-71.
40. Bouwes Bavinck JN, Stark S, Petridis AK, et al. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated human papillomavirus type 8 in patients with actinic keratoses. Br J Dermatol. 2000;142(1):103-109.
41. Karagas MR, Nelson HH, Sehr P, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst. 2006;98(6):389-395.
42. Hall L, Struijk L, Neale RE, Feltkamp MCW. Re: Human Papillomavirus and incidence of squamous cell and basal cell carcinomas of skin. J Natl Cancer Inst. 2006;98(19):1425-1426.
43. Purdie KJ, Pennington J, Proby CM, et al. The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J. 1999;18(19):5359-5369.
44. de Villiers E-M, Ruhland A, Sekaric P. Human papillomaviruses in nonmelanoma skin cancer. Semin Cancer Biol. 1999;9:413-422.
45. Harwood CA, Spink PJ, Surentheran T, et al. Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol. 1999;37(11):3545-3555.
46. Berkhout RJM, Bouwes Bavinck JN, Ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol. 2000;38(6):2087-2096.
47. Purdie KJ, Surentheran T, Sterling JC, et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol. 2005;125(1):98-107.